{"schema_version":"secwatch.filing_event.v1","accession":"0001625297-26-000028","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2026-09-15T20:28:36+00:00","discovered_at":"2026-09-15T20:29:00.313466+00:00","generated_at":"2026-09-15T20:29:08.327307+00:00","sec_items":["1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Indivior accelerates RB copacker supply deal termination to Jan 15, 2027","bullets":["Indivior UK and Reckitt Benckiser Healthcare UK terminated Copacker Supply Agreement effective Jan 15, 2027, vs original Dec 31, 2027.","RB to manufacture additional volumes of SUBOXONE/SUBUTEX tablets before termination; Indivior identified a new supplier.","Indivior to pay RB costs (under absorption, asset disposal, redundancy, incentive) that are fixed/capped and stated as not material.","New supplier agreement not expected to be material and enforceable only after validation of manufacturing process."],"urls":{"canonical":"https://secwatch.observer/filing/0001625297-26-000028","json":"https://secwatch.observer/filing/0001625297-26-000028.json","markdown":"https://secwatch.observer/filing/0001625297-26-000028.md","text":"https://secwatch.observer/filing/0001625297-26-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000162529726000028/0001625297-26-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000162529726000028/indv-20260909.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-15T20:29:08.327307+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}